Startup-084
Monheim, Germany
Bimyo GmbH = first-in-class Myocardiac Infarction Treatment with a patented Mode-of-Action
Monheim, Germany
Bimyo GmbH = first-in-class Myocardiac Infarction Treatment with a patented Mode-of-Action
Melbourne, USA Florida
Alertgy has developed a wearable noninvasive continous blood glucose monitor and alert system that measures more than just glucose for diabetics.
Monheim am Rhein, Germany
Transferring knowledge from cutting-edge research, we will be launching immune system strengthening nutritional supplements (first-in-class synbiotics) and distribute them globally as a life-style product.
Hannover, Germany
We are improving the life of millions of glaucoma patients in the world by introducing our breakthrough EYEMATE system for remote disease care.
Rehovot, Israel
TargetGene is developing radically safer cell-therapies for Immune-disorders and Cancer using it’s ultra-precise gene-editing platform